Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,275
Out of 5,124 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $109.08 | +10.01% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $78.10 | +66.45% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $74.70 | +47.26% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $6.32 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $69.89 | -55.29% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $33.90 | +3.24% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $105.89 | +178.59% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $65.03 | +39.94% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $64.86 | -58.37% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $243.15 | -72.44% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $109.08
Upside: +10.01%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $78.10
Upside: +66.45%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $74.70
Upside: +47.26%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $6.32
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $69.89
Upside: -55.29%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $33.90
Upside: +3.24%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $105.89
Upside: +178.59%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $65.03
Upside: +39.94%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $64.86
Upside: -58.37%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $243.15
Upside: -72.44%